ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag policy work life balance drug development careers workplace

2016 Life Sciences Salary Survey
Karen Zusi | Nov 1, 2016 | 10+ min read
Most researchers feel stimulated by their work but are dissatisfied with their compensation, according to this year’s results.
Turning Points: Women Transform the Life Sciences Workplace
Karen Young Kreeger | Mar 3, 2002 | 2 min read
When I gave birth to my son a couple of years ago, I wondered how I would balance my work and family life, day to day. How would I meet a big deadline if the daycare center informed me my son had a fever? What would happen if my train from the office got delayed? I decided to work at home, and with my husband's help, my family has muddled through. Bench scientists usually can't work at home, however. They can only seek employers who will allow them to dash to daycare centers should their childr
Best Places to Work Industry 2013
The Scientist | Jun 1, 2013 | 6 min read
Our final survey of the life-science industry workplace highlights the companies—small and large, domestic and international—that are making their researchers feel valued and at home.
Going Governmental
Rachel Nuwer | Dec 1, 2011 | 8 min read
Federal agencies offer interesting opportunities for researchers looking to do more than bench work.
Best Places to Work Academia, 2012
The Scientist | Aug 1, 2012 | 9 min read
On the 10th anniversary of The Scientist’s survey of life science academics, institutions are contending with tighter budgets and larger administrative staffs, while working to sustain and inspire their researchers.
Balancing Academic Research And Motherhood Is A Precarious Task
Ricki Lewis | Sep 17, 1995 | 6 min read
Precarious Task Author: Ricki Lewis In the days of TV's June Cleaver -- stay-at-home-mom extraordinaire -- the idea of the female parent spending hours each day lecturing undergraduates or directing laboratory research bordered on absurd. Women were rare among the ranks of academic scientists, and those who were also mothers rarer still. Today women are prominent players in the academic life sciences, and many are mothers, too. Like their counterparts in industry (R. Lewis, The Scientist, Jan.
The Best Places to Work in Industry
Maria Anderson | Jun 20, 2004 | 7 min read
The formula for the best workplace: a product to be proud of, appreciative management, and trustworthy colleagues. That's the opinion of participants in The Scientist's Best Places to Work in Industry survey.Our 2004 survey aimed to define what attracts highly talented workers to a company, and what initiatives keep those workers happy once they sign on. We also asked survey participants to identify the employers who come closest to realizing these ideals.Pride in the product ranked first among
National AIDS Task Force Expected To Accelerate Drug Development
Franklin Hoke | Feb 6, 1994 | 8 min read
Bench scientists will play a major role in an ambitious effort to streamline the campaign against HIV The soon-to-be-appointed National Task Force on AIDS Drug Development may have a strong, positive impact on the research and development of antiviral therapies to counter HIV infection, say industry and academic scientists, government officials organizing the task force, and members of the AIDS-affected community. Key to the task
The Pleasures and Perils of Scientists in Industry
Paula Park | Jun 15, 2003 | 10+ min read
Photos courtesy of TransForm Pharmaceuticals (left) and Pioneer Hi-Bred(center and right) The majority of participants in The Scientist's "Best Places in to Work for Scientists in Industry" survey reported that they valued their workplaces because the companies maintained industry standards, kept promises, and sustained the staffs' pride in their work. The magazine asked employees in life sciences companies to evaluate their own workplaces and identify company characteristics that employees c
Concerns over Efficacy and Cost of Muscle Wasting Treatments
Ruth Williams | Nov 11, 2020 | 5 min read
Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.

Run a Search

ADVERTISEMENT